1 active not recruiting, 1 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Completed 1 |
Follow trilaciclib: new trials by email Literature Review of trilaciclib trials Research Report on trilaciclib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan Trilaciclib, Placebo, Topotecan - Extensive-stage Small-cell Lung Cancer | Phase 4 | Active not recruiting | Pharmacosmos A/S | 302 | 2023-10-13 | 2026-10-05 |
| Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study Trilaciclib - Extensive-stage Small-cell Lung Cancer | Phase 4 | Completed | Jiangsu Simcere Pharmaceutical Co., Ltd. | 30 | 2021-08-11 | 2023-10-06 |
Jiangsu Simcere Pharmaceutical Co., Ltd. (1) · Pharmacosmos A/S (1)
China (1) · Spain (1)
Yongxing Chen (1)